QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™ Video QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™ Learn how Certara IQ’s IBD model enables simulation of complex immune pathways to optimize therapeutic…CertaraOctober 16, 2025
Modeling Alzheimer’s Disease with Certara IQ™ Video Modeling Alzheimer’s Disease with Certara IQ™ Explore Certara IQ’s Alzheimer’s Disease model, enabling researchers to simulate neurodegenerative pathways, test therapies, and…CertaraOctober 16, 2025
Early Feasibility Assessment (EFA) with Certara IQ™ Video Early Feasibility Assessment (EFA) with Certara IQ™ Learn how Certara IQ performs early feasibility assessments (EFA) to predict biotherapeutic dosing, guide candidate…CertaraOctober 16, 2025
Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence Video Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence Learn how Certara IQ predicts recommended Phase 2 doses using advanced QSP modeling workflows that…CertaraOctober 16, 2025
Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection Video Certara IQ™: Model-Informed First-In-Human (FIH) Dose Selection Discover how Certara IQ uses QSP modeling to predict safe and effective First-In-Human doses, accelerating…CertaraOctober 16, 2025
Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton Video Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton Hear from Certara experts on how Certara IQ modernizes QSP modeling with AI, collaboration tools,…CertaraOctober 16, 2025
PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software Live Events PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software – Scarman, Coventry, UKCertaraOctober 14, 2025
Exploring the Population Pharmacokinetic and Pharmacogenetics Characteristics of Flurbiprofen Isomers in Selective Joint Replacement Patients with Postoperative Pain Publication Exploring the Population Pharmacokinetic and Pharmacogenetics Characteristics of Flurbiprofen Isomers in Selective Joint Replacement Patients with Postoperative Pain Find out how Phoenix NLME identifies pharmacogenetic drivers of flurbiprofen enantiomer clearance and CSF distribution…CertaraOctober 9, 2025